K. Hede

发表

Environmental Control of Annual Ovarian Cycle in the Toad Bufo bufo bufo L.: Role of Temperature

L. Larsen, C. Jørgensen, K. Hede, 1978 .

Assessing survivorship care plans.

K. Hede, 2011, Journal of the National Cancer Institute.

Breast cancer testing scandal shines spotlight on black box of clinical laboratory testing.

K. Hede, 2008, Journal of the National Cancer Institute.

Agencies look to patient navigators to reduce cancer care disparities.

K. Hede, 2006, Journal of the National Cancer Institute.

Blocking cancer with RNA interference moves toward the clinic.

K. Hede, 2005, Journal of the National Cancer Institute.

Which came first? Studies clarify role of aneuploidy in cancer.

K. Hede, 2005, Journal of the National Cancer Institute.

Preoperative MRI in breast cancer grows contentious.

K. Hede, 2009, Journal of the National Cancer Institute.

Drilling down to the causes of racial disparities in lung cancer.

K. Hede, 2010, Journal of the National Cancer Institute.

Research groups promoting proton therapy "lite".

K. Hede, 2006, Journal of the National Cancer Institute.

Doctors seek to prevent breast cancer recurrence by lowering insulin levels.

K. Hede, 2008, Journal of the National Cancer Institute.

Studies define role of microRNA in cancer.

Karyn Hede, K. Hede, 2005, Journal of the National Cancer Institute.

Environmental protection: studies highlight importance of tumor microenvironment.

K. Hede, 2004, Journal of the National Cancer Institute.

Imprinting may provide cancer prevention tools.

K. Hede, 2007, Journal of the National Cancer Institute.

Project data sphere to make cancer clinical trial data publicly available.

Karyn Hede, K. Hede, 2013, Journal of the National Cancer Institute.

$104 million proteomics initiative gets green light.

K. Hede, 2005, Journal of the National Cancer Institute.

Histone deacetylase inhibitors sit at crossroads of diet, aging, cancer.

K. Hede, 2006, Journal of the National Cancer Institute.

Small RNAs are raising big expectations.

K. Hede, 2009, Journal of the National Cancer Institute.

PTEN takes center stage in cancer stem cell research, works as tumor suppressor.

K. Hede, 2006, Journal of the National Cancer Institute.

Antibiotic resistance: An infectious arms race

K. Hede, 2014, Nature.

Superhighway or blind alley? The cancer genome atlas releases first results.

K. Hede, 2008, Journal of the National Cancer Institute.

Managing Scientists

K. Hede, K. Hede, 2007, Science.

Chemobrain is real but may need new name.

K. Hede, 2008, Journal of the National Cancer Institute.

Hints that statins reduce colon cancer risk finally being put to the test.

K. Hede, 2011, Journal of the National Cancer Institute.

Chinese folk treatment reveals power of arsenic to treat cancer, new studies under way.

K. Hede, 2007, Journal of the National Cancer Institute.

Rexinoids may be ready for prime time in prevention, but challenges remain.

K. Hede, 2004, Journal of the National Cancer Institute.

Lung cancer may be different for men and women, but researchers ponder what to do?

K. Hede, 2007, Journal of the National Cancer Institute.

Gastric cancer: trastuzumab trial results spur search for other targets.

K. Hede, 2009, Journal of the National Cancer Institute.

Supportive care: large studies ease yoga, exercise into mainstream oncology.

K. Hede, 2011, Journal of the National Cancer Institute.

Radioactive "seed" implants may rival surgery for low-risk prostate cancer patients.

K. Hede, 2007, Journal of the National Cancer Institute.

Drilling down to the causes of racial disparities in lung cancer.

K. Hede, 2010, Journal of the National Cancer Institute.